Basit öğe kaydını göster

dc.contributor.authorYener, Gulgun
dc.contributor.authorAydogmus, Zeynep
dc.contributor.authorKaraman, Ecem Fatma
dc.contributor.authorGonullu, Umit
dc.contributor.authorUner, Melike
dc.date.accessioned2021-03-04T12:55:05Z
dc.date.available2021-03-04T12:55:05Z
dc.date.issued2015
dc.identifier.citationGonullu U., Uner M., Yener G., Karaman E. F. , Aydogmus Z., "Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery", ACTA PHARMACEUTICA, cilt.65, sa.1, ss.1-13, 2015
dc.identifier.issn1330-0075
dc.identifier.otherav_79bcf04d-1481-41dd-9552-4e640a8f8c71
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/83435
dc.identifier.urihttps://doi.org/10.1515/acph-2015-0009
dc.description.abstractSolid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were prepared for the treatment of painful and inflammatory conditions of the skin. Compritol (R) 888 ATO, Lanette (R) O and oleic acid were used as solid and liquid lipids. SLN, NLC and NE were found physically stable at various temperatures for 6 months. Case I diffusional drug release was detected as the dominant mechanism indicating Fickian drug diffusion from nanoparticles and nanoemulsion. The highest rate of drug penetration through rat skin was obtained with NE followed by NLC, SLN and a gel formulation. Nanoformulations significantly increased drug penetration through rat skin compared to the gel (p < 0.05). Thus, SLN, NLC and NE of LRX can be suggested for relieving painful and inflammatory conditions of the skin.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleFormulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery
dc.typeMakale
dc.relation.journalACTA PHARMACEUTICA
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume65
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.endpage13
dc.contributor.firstauthorID48414


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster